The
Cell and Marrow Processing Lab prepares peripheral blood and bone marrow
for patients receiving either autologous or allogenic hemopoietic stem
cell transplants. This often involves extensive processing and manipulation
such as T-depletion or gene transfer. Many components are enriched for
CD34 progenitor cells prior to further processing either with positive
selection devices or cell sorting. This transplant service maintains
a patient base for the implementation of the gene therapy strategies.

The
National Heart, Lung, and Blood Institute (NHLBI), a part of the National
Institutes of Health (NIH), is supporting the initiative for an Administrative
Center and three facilities for the production and testing of novel
somatic (biological) cell therapies. Baylor College of Medicine's Center
for Cell and Gene Therapy is one of these facilities.
The NHLBI is providing funding to these facilities for the manufacture
of cellular therapy products. Product requests for clinical grade products,
basic research, and/or non-human use will be accepted, evaluated, and,
if approved, assigned to a facility for manufacture.
For further information contact the PACT website at: www.pactgroup.org